Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Chappey · SciRah

Researcher profile · Semantic Scholar

C. Chappey

Share profile

C. Chappey — researcher profile on SciRah

h-index: 37
Works: 70
Citations: 5,724

Most-cited papers

Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies
J. Binley, T. Wrin, B. Korber, M. B. Zwick +8 more
2004Journal of Virology774 citations Open access
Semantic Scholar
Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection.
S. Frost, T. Wrin, Davey M. Smith, Sergei L. Kosakovsky Pond +8 more
2005Proceedings of the National Academy of Sciences of the United States of America382 citations Open access
Semantic Scholar
Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism
J. Whitcomb, Wei Huang, Signe Fransen, K. Limoli +6 more
2006Antimicrobial Agents and Chemotherapy377 citations Open access
Semantic Scholar
Cn3D: sequence and structure views for Entrez.
Yan-Li Wang, L. Geer, C. Chappey, J. Kans +1 more
2000TIBS -Trends in Biochemical Sciences. Regular ed284 citations
Semantic Scholar
An Evolutionary Model-Based Algorithm for Accurate Phylogenetic Breakpoint Mapping and Subtype Prediction in HIV-1
Sergei L. Kosakovsky Pond, D. Posada, Eric W. Stawiski, C. Chappey +6 more
2009PLoS Comput. Biol.257 citations Open access
Semantic Scholar
Evidence for Positive Epistasis in HIV-1
S. Bonhoeffer, C. Chappey, N. Parkin, Jeanette M Whitcomb +1 more
2004Science249 citations
Semantic Scholar
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.
J. Whitcomb, N. Parkin, C. Chappey, N. Hellmann +1 more
2003Journal of Infectious Diseases238 citations
Semantic Scholar
A web-based genotyping resource for viral sequences
M. Rozanov, U. Plikat, C. Chappey, A. Kochergin +1 more
2004Nucleic Acids Res.225 citations Open access
Semantic Scholar
Characterization of Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Variation and Neutralizing Antibody Responses during Transmission of HIV-1 Subtype B
S. Frost, Yang Liu, Sergei L Kosakovsky Pond, C. Chappey +4 more
2005Journal of Virology203 citations Open access
Semantic Scholar
A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase
Trevor Hinkley, Joao Martins, C. Chappey, M. Haddad +4 more
2011Nature Genetics187 citations
Semantic Scholar
A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism
M. Nijhuis, N. V. van Maarseveen, S. Lastère, P. Schipper +15 more
2007PLoS Medicine177 citations Open access
Semantic Scholar
Molecular epidemiology of 58 new African human T-cell leukemia virus type 1 (HTLV-1) strains: identification of a new and distinct HTLV-1 molecular subtype in Central Africa and in Pygmies
R. Mahieux, F. Ibrahim, P. Mauclère, V. Hervé +10 more
1997Journal of Virology157 citations Open access
Semantic Scholar
Database resources of the National Center for Biotechnology Information
D. Wheeler, C. Chappey, A. Lash, D. Leipe +4 more
2000Nucleic Acids Res.154 citations Open access
Semantic Scholar
Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys
Michael C. Müller, N. Saksena, E. Nerrienet, C. Chappey +6 more
1993Journal of Virology132 citations Open access
Semantic Scholar
A Phase II Study of Talazoparib after Platinum or Cytotoxic Nonplatinum Regimens in Patients with Advanced Breast Cancer and Germline BRCA1/2 Mutations (ABRAZO)
N. Turner, M. Telli, H. Rugo, A. Mailliez +10 more
2018Clinical Cancer Research128 citations
Semantic Scholar
Natural Variation of Drug Susceptibility in Wild-Type Human Immunodeficiency Virus Type 1
N. Parkin, N. Hellmann, J. Whitcomb, Linda D. B. Kiss +2 more
2004Antimicrobial Agents and Chemotherapy112 citations Open access
Semantic Scholar
Structure and variations of feline immunodeficiency virus envelope glycoproteins.
G. Pancino, I. Fossati, C. Chappey, S. Castelot +4 more
1993Virology112 citations
Semantic Scholar
Improving lopinavir genotype algorithm through phenotype correlations: novel mutation patterns and amprenavir cross-resistance
N. Parkin, C. Chappey, C. Petropoulos
2003AIDS (London)111 citations Open access
Semantic Scholar
Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus
R. Draenert, Todd M. Allen, Yang Liu, T. Wrin +10 more
2006Journal of Experimental Medicine100 citations Open access
Semantic Scholar
Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors
T. Yap, A. Bardia, M. Dvorkin, M. Galsky +16 more
2022JAMA Oncology98 citations Open access
Semantic Scholar
Simian T-Cell Lymphotropic Virus Type 1 from Mandrillus sphinx as a Simian Counterpart of Human T-Cell Lymphotropic Virus Type 1 Subtype D
R. Mahieux, C. Chappey, M. Georges-Courbot, G. Dubreuil +3 more
1998Journal of Virology93 citations Open access
Semantic Scholar
Clinical activity, safety and predictive biomarkers of the engineered antibody MPDL3280A (anti-PDL1) in non-small cell lung cancer (NSCLC): update from a phase Ia study.
L. Horn, D. Spigel, S. Gettinger, S. Antonia +7 more
201587 citations
Semantic Scholar
Clinical activity and safety from a phase II study (FIR) of MPDL3280A (anti-PDL1) in PD-L1–selected patients with non-small cell lung cancer (NSCLC).
D. Spigel, J. Chaft, S. Gettinger, Bo H. Chao +8 more
201582 citations
Semantic Scholar
B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins
G. Pancino, C. Chappey, W. Saurin, P. Sonigo
1993Journal of Virology78 citations Open access
Semantic Scholar
Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations
M. Jordan, M. Kearney, S. Palmer, W. Shao +5 more
2010Journal of Virological Methods69 citations Open access
Semantic Scholar
Final results of a phase 2 study of talazoparib (TALA) following platinum or multiple cytotoxic regimens in advanced breast cancer patients (pts) with germline BRCA1/2 mutations (ABRAZO).
N. Turner, M. Telli, H. Rugo, A. Mailliez +11 more
201760 citations
Semantic Scholar
Human Immunodeficiency Virus Type 1 Protease-Correlated Cleavage Site Mutations Enhance Inhibitor Resistance
M. Kolli, Eric W. Stawiski, C. Chappey, C. Schiffer
2009Journal of Virology59 citations Open access
Semantic Scholar
Phenotypic and genotypic HIV-1 drug resistance assays provide complementary information.
N. Parkin, C. Chappey, L. Maroldo, M. Bates +2 more
2002Journal of Acquired Immune Deficiency Syndromes58 citations Open access
Semantic Scholar
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors
A. Schram, N. Colombo, E. Arrowsmith, V. Narayan +19 more
2022JAMA Oncology56 citations Open access
Semantic Scholar
Phenotypic impact of HIV reverse transcriptase M184I/V mutations in combination with single thymidine analog mutations on nucleoside reverse transcriptase inhibitor resistance
L. Ross, N. Parkin, C. Chappey, R. Fisher +4 more
2004AIDS (London)50 citations Open access
Semantic Scholar
Maintenance of an Intact Human Immunodeficiency Virus Type 1 vpr Gene following Mother-to-Infant Transmission
Venkat R. K. Yedavalli, C. Chappey, N. Ahmad
1998Journal of Virology49 citations Open access
Semantic Scholar
Selective pressure exerted by immunodominant HIV‐1‐specific cytotoxic T lymphocyte responses during primary infection drives genetic variation restricted to the cognate epitope
H. Soudeyns, S. Paolucci, C. Chappey, Mary Beth Daucher +5 more
1999European Journal of Immunology46 citations Open access
Semantic Scholar
Quantitation of HER2 Expression or HER2:HER2 Dimers and Differential Survival in a Cohort of Metastatic Breast Cancer Patients Carefully Selected for Trastuzumab Treatment Primarily by FISH
C. Desmedt, J. Sperinde, F. Piette, Weidong Huang +12 more
2009Diagnostic molecular pathology (Print)45 citations
Semantic Scholar
Development of an HIV-1 Reference Panel of Subtype B Envelope Clones Isolated From the Plasma of Recently Infected Individuals
Becky Schweighardt, Yang Liu, Wei Huang, C. Chappey +3 more
2007Journal of Acquired Immune Deficiency Syndromes45 citations
Semantic Scholar
The K101P and K103R/V179D Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nonnucleoside Reverse Transcriptase Inhibitors
N. Parkin, Soumi Gupta, C. Chappey, C. Petropoulos
2006Antimicrobial Agents and Chemotherapy43 citations Open access
Semantic Scholar
Prevalence, Genotypic Associations and Phenotypic Characterization of K65R, L74V and other HIV-1 RT Resistance Mutations in a Commercial Database
D. Mccoll, C. Chappey, N. Parkin, Michael D. Miller
2008Antiviral Therapy40 citations Open access
Semantic Scholar
Conservation of an Intact vif Gene of Human Immunodeficiency Virus Type 1 during Maternal-Fetal Transmission
Venkat R. K. Yedavalli, C. Chappey, E. Matala, N. Ahmad
1998Journal of Virology40 citations Open access
Semantic Scholar
Phenotypic susceptibility to didanosine is associated with antiviral activity in treatment-experienced patients with HIV-1 infection.
P. Flandre, C. Chappey, A. Marcelin, Kirk A. Ryan +6 more
2007Journal of Infectious Diseases28 citations Open access
Semantic Scholar
Clinical trials of MPDL3280A (anti-PDL1) in patients (pts) with non-small cell lung cancer (NSCLC).
N. Rizvi, L. Chow, Luc Y. Dirix, S. Gettinger +9 more
201427 citations
Semantic Scholar
Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers
B. Brennan, B. Davies, G. Cirrincione-Dall, P. N. Morcos +5 more
2012Antimicrobial Agents and Chemotherapy26 citations Open access
Semantic Scholar
Diversity of the V3 region of HIV in Paris, France
M. Chaix, C. Chappey, I. Couillin, W. Rozenbaum +2 more
1993AIDS (London)23 citations
Semantic Scholar
Differences in Reversion of Resistance Mutations to Wild-Type under Structured Treatment Interruption and Related Increase in Replication Capacity
A. Paquet, J. Baxter, J. Weidler, Yolanda S. Lie +5 more
2011PLoS ONE22 citations Open access
Semantic Scholar
Antiretroviral drug susceptibility among drug-naive adults with recent HIV infection in Rakai, Uganda
S. Eshleman, O. Laeyendecker, N. Parkin, Wei Huang +8 more
2009AIDS (London)19 citations Open access
Semantic Scholar
Immune biomarkers associated with clinical benefit from atezolizumab (MPDL3280a; anti-PD-L1) in advanced urothelial bladder cancer (UBC)
T. Powles, D. Nickles, E. V. Van Allen, C. Chappey +14 more
2015Journal of Immunotherapy for Cancer17 citations Open access
Semantic Scholar
Abstract P1-19-03: JAVELIN PARP Medley, a phase 1b/2 study of avelumab plus talazoparib: Results from advanced breast cancer cohorts
T. Yap, P. Konstantinopoulos, M. Telli, S. Saraykar +15 more
202016 citations
Semantic Scholar
High variability of the gag/pol transframe region among HIV-1 isolates.
D. Candotti, C. Chappey, M. Rosenheim, P. M'pelé +2 more
1994Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie16 citations
Semantic Scholar
Safety, Virology and Pharmacokinetics of Oseltamivir in Infants with Laboratory-Confirmed Influenza: A Phase I/II, Prospective, Open-Label, Multicentre Clinical Trial
B. Rath, J. Brzostek, S. Guillén, Vis Niranjan +3 more
2015Antiviral Therapy10 citations
Semantic Scholar
Principal component analysis of general patterns of HIV-1 replicative fitness in different drug environments.
Joao Martins, C. Chappey, M. Haddad, J. Whitcomb +3 more
2010Epidemics9 citations Open access
Semantic Scholar
JAVELIN BRCA/ATM: A phase 2 trial of avelumab (anti–PD-L1) plus talazoparib (PARP inhibitor) in patients with advanced solid tumors with a BRCA1/2 or ATM defect.
D. Hyman, A. Zelnak, T. Bauer, S. Ulahannan +7 more
2019Journal of Clinical Oncology8 citations
Semantic Scholar
Differential Impact of Thymidine Analogue Mutations on Emtricitabine and Lamivudine Susceptibility
L. Ross, N. Parkin, P. Gerondelis, C. Chappey +3 more
2006Journal of Acquired Immune Deficiency Syndromes8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Petropoulos×15
Invite
C. Petropoulos — researcher profile on SciRah
N. Parkin×11
Invite
N. Parkin — researcher profile on SciRah
T. Wrin×6
Invite
T. Wrin — researcher profile on SciRah
J. Whitcomb×5
Invite
J. Whitcomb — researcher profile on SciRah

×5

Invite

M. Telli — researcher profile on SciRah

Invite

M. Bates — researcher profile on SciRah

Invite

Yang Liu — researcher profile on SciRah

Eric W. Stawiski×4

Invite

Eric W. Stawiski — researcher profile on SciRah

Invite

T. Yap — researcher profile on SciRah

Invite

R. Stewart — researcher profile on SciRah

Invite

S. Frost — researcher profile on SciRah

Invite

Wei Huang — researcher profile on SciRah